Do Cancer Genetics Impact Treatment Decision Making? Immunotherapy and Beyond in the Management of Advanced and Metastatic Urothelial Carcinoma

Bladder cancer is one of the most commonly diagnosed genitourinary malignancies. For many years, the primary treatment for metastatic urothelial cancer (mUC) was predicated on the use of platinum-based chemotherapy. More recently, immune checkpoint inhibitors (ICIs) were approved by regulatory agenc...

Descripción completa

Detalles Bibliográficos
Autores principales: Hui, Gavin, Stefanoudakis, Dimitrios, Zektser, Yuliya, Isaacs, Dayna Jill, Hannigan, Christopher, Pantuck, Allan J., Drakaki, Alexandra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10452970/
https://www.ncbi.nlm.nih.gov/pubmed/37623017
http://dx.doi.org/10.3390/curroncol30080536

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10452970/
https://www.ncbi.nlm.nih.gov/pubmed/37623017
http://dx.doi.org/10.3390/curroncol30080536

Ejemplares similares